Pascal Soriot (Photo by Chris Jackson/Getty Images)

As­traZeneca's Pas­cal So­ri­ot brought home near­ly $19M last year, dwarf­ing some of Eu­rope's high­est phar­ma pay pack­ages

Amid what Pas­cal So­ri­ot called an “ex­cep­tion­al year in terms of rev­enue” for As­traZeneca, the chief ex­ec­u­tive took home near­ly $19 mil­lion — a slight cut from last year’s pay, but still com­ing in mil­lions above what his fel­low Eu­ro­pean phar­ma CEOs took home last year.

So­ri­ot raked in £13.8 mil­lion ($18.8 mil­lion) in 2021, about £1.3 mil­lion ($1.8 mil­lion) of which was con­sid­ered base pay. In the com­pa­ny’s re­cent Q4 call with in­vestors, he said As­traZeneca achieved its high­est rev­enue num­bers yet, putting it on track to reach its $40 bil­lion an­nu­al rev­enue goal this year — one year ahead of sched­ule. Some of that suc­cess is at­trib­uted to the com­pa­ny’s Covid-19 cam­paign, which reg­is­tered $4.1 bil­lion in 2021 rev­enue.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.